Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 24
Phase 31

Trial Status

Recruiting5

Role Distribution

Principal Investigator4
Other Roles1
PI Rate80%

Activity Timeline

Clinical Trials (5)

NCT06851663Phase 2/3Recruiting
Trop2-targeted immunoPET Imaging of Solid Tumors
Bladder CancerCervical CancerCholangiocarcinoma+11 more
PrincipalinvestigatorStart date: 2024-12-23
NCT06852638Phase 2Recruiting
CD70-targeted immunoPET Imaging of Malignant Cancers
Follicular LymphomaLymphomaLymphoma, Large B-Cell, Diffuse+4 more
PrincipalinvestigatorStart date: 2024-12-23
NCT06680089Phase 2Recruiting
CD70-targeted immunoPET Imaging of Kidney Cancer
Kidney NeoplasmsNeoplasmsUrogenital Neoplasms+1 more
PrincipalinvestigatorStart date: 2024-11-27
NCT06602037Not ApplicableRecruiting
ImmunoPET Imaging of Pancreatic Cancer
Neoplasms Pancreatic
PrincipalinvestigatorStart date: 2024-11-20
NCT06715826Phase 1/2Recruiting
Target-specific immunoPET Imaging of Breast Cancer
Breast CancerBreast Cancer MetastaticBreast Neoplasms
StudychairStart date: 2024-09-21

Research Network

Collaboration Network

4 collaborators·3 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jianjun Liu, Ph.D. & M.D.

Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

Very Similar
2 trials

Shared therapeutic areas:

Urinary Bladder CancerCancer of the Uterine CervixCholangiocarcinoma+18 more

Worked with same sponsors:

RenJi Hospital
Collaborated on 2 trials
Similarity Score218%

Wei Zhai, Ph.D. & M.D.

Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

Moderately Similar
1 trials

Shared therapeutic areas:

Kidney NeoplasmsNeoplasmsUrogenital Neoplasms+1 more

Worked with same sponsors:

RenJi Hospital
Collaborated on 1 trial
Similarity Score44%

Jianjun Liu, PhD

Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University

Related
1 trials

Shared therapeutic areas:

Neoplasms Pancreatic

Worked with same sponsors:

RenJi Hospital
Collaborated on 1 trial
Similarity Score14%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Breast CancerOvary CancerCancer of the Uterine Cervix+4 more
Similarity Score7%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Cancer of LiverLung CancerBreast Cancer+4 more
Similarity Score7%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Lung CancerNeoplasmsBreast Cancer+2 more
Similarity Score5%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerSolid TumorEndometrial Carcinoma+2 more
Similarity Score5%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Breast CancerProstate CancerCancer of Head and Neck+2 more
Similarity Score5%

Lizhi Niu, PhD

Fuda Cancer Hospital

Related
31 trials

Shared therapeutic areas:

Cancer of LiverBreast CancerLung Cancer+1 more
Similarity Score4%

Francesco Perrone, M.D., Ph.D.

National Cancer Institute, Naples

Related
13 trials

Shared therapeutic areas:

Ovary CancerCancer of the Uterine CervixEndometrial Carcinoma+1 more
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06851663Phase 2/3PrincipalInvestigator

Trop2-targeted immunoPET Imaging of Solid Tumors

Bladder CancerCervical CancerCholangiocarcinoma+11 more
Recruiting
NCT06852638Phase 2PrincipalInvestigator

CD70-targeted immunoPET Imaging of Malignant Cancers

Follicular LymphomaLymphomaLymphoma, Large B-Cell, Diffuse+4 more
Recruiting
NCT06680089Phase 2PrincipalInvestigator

CD70-targeted immunoPET Imaging of Kidney Cancer

Kidney NeoplasmsNeoplasmsUrogenital Neoplasms+1 more
Recruiting
NCT06602037Not ApplicablePrincipalInvestigator

ImmunoPET Imaging of Pancreatic Cancer

Neoplasms Pancreatic
Recruiting
NCT06715826Phase 1/2StudyChair

Target-specific immunoPET Imaging of Breast Cancer

Breast CancerBreast Cancer MetastaticBreast Neoplasms
Recruiting

All 5 trials loaded